Insiders AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:01 17/04/2026 pm IST			5-day change	1st Jan Change
15,118.00 ^GBX	+1.72%		-0.74%	+9.63%

11:43am	AstraZeneca's tozorakimab delivers sharp reduction in COPD flare-ups	RE
18/04	Innate Pharma SA to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026	CI

Insiders

15/04	Prelude Therapeutics Incorporated Appoints Charles Morris as Chief Medical Officer, Effective April 20, 2026	CI
14/04	Asgard Therapeutics Appoints Wolfram Brugger as Chief Medical Officer	CI
13/04	Orum Therapeutics, Inc. Appoints Maria Koehler and Geoff Meyerson to Board of Directors	CI
10/04	Cardiff Oncology, Inc. Announces Management Appointments	CI
02/04	Harmony Biosciences Holdings, Inc. Announces Management Changes	CI
30/03	Sai Life Sciences Limited Announces Management Changes	CI
25/03	Suzhou Ribo Life Science Co., Ltd. Announces Executive Appointments, Effective March 25, 2026	CI
23/03	Aurinia Pharmaceuticals Inc. Announces Board and Executive Changes	CI
23/03	Aurinia Pharmaceuticals Inc. Announces Chief Executive Officer Changes	CI
19/03	Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation	CI
12/03	Poolbeg Pharma plc Appoints Adrian Kilcoyne to Scientific Advisory Board	CI
12/03	Ipsen Announces Executive Changes	CI
10/03	Spago Nanomedical AB Appoints Torsten Malmström as Director CMC & Supply and Management Team Member	CI
09/03	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
05/03	Vicore Pharma Holding AB Announces Executive Changes	CI
04/03	NervGen Pharma Corp. Announces Executive Changes	CI
02/03	Apellis Pharmaceuticals, Inc. Appoints Mikael Dolsten to Board of Directors, Effective March 1, 2026	CI
24/02	AstraZeneca PLC Announces Directorate And Committee Changes, Effective April 9, 2026	CI
24/02	AstraZeneca announces retirement of non-executive director Nazneen Rahman	RE
24/02	Tectonic Therapeutic, Inc. Announces Board and Committees Changes	CI
18/02	Gensight Biologics Announces Executive Changes	CI
17/02	Camurus Appoints Jane Buus Laursen as Chief Corporate Development Officer, Effective March 23, 2026	CI
13/02	NatWest results ahead of forecasts, ups dividend 51%	AN
12/02	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
12/02	China charges former AstraZeneca regional head Leon Wang	RE